One study explored the potential risk of sarcopenia among carriers of PNPLA3 variants; DEXA-derived ASM independently decreased in NAFLD patients carrying the wild type gene, but no association was found among PNPLA3 subjects who carried the risk allele (77). This evidence concerns the gene PNPLA3 and sarcopenia.